Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siponimod in relapsing-remitting multiple sclerosis (extension study)
NCT01185821Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2010
- Primary completion
- Oct 2016
- Countries
- 12
01
Overview
Phase 2, double-blind trial of siponimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Novartis. Started Aug 2010; status: completed.
02
Drugs
siponimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01185821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185821.